LONDON (The Deal) -- European and Asian stocks rose Monday as it looked increasingly likely that the new chairman of the Federal Reserve will keep monetary policy looser for longer after former Treasury Secretary Larry Summers withdrew his candidature. Summers' retreat leaves Federal Reserve Vice Chair Janet Yellen, who is perceived to be more dovish than Summers, in pole position for the job.
A weekend deal between U.S. and Russia about how to tackle Syria's chemical weapons was seen as taking the Western world further back from the brink of military action in the civil war-ravaged country.
The Hang Seng closed up 337.13, or 1.47%, at 23,251.41, while the Nikkei edged 17.40 higher at 14,404.67. In Germany, the Dax by late morning was up 100.82, or 1.18%, at 8,610.24. A decisive victory for the right-of-center Christian Social Union in weekend state elections in Bavaria boded well for Chancellor Angela Merkel's allied Christian Democrats in national elections on Sept. 23, even though Merkel's minority coalition partner, the pro-business Free Democrats, performed badly in the southern German state.
Best Income Companies To Buy Right Now: Intellipharmaceutics International Inc.(IPCI)
Intellipharmaceutics International Inc. engages in the research, development, and manufacture of novel or generic controlled and targeted release oral solid dosage drugs. The company?s patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of various existing and new pharmaceuticals. It has a pipeline of products in various stages of development in therapeutic areas, including neurology, cardiovascular, and gastrointestinal tract, pain, and infection. The company?s lead generic product under development includes generic Focalin XR (dexmethylphenidate hydrochloride), an extended-release capsule for the treatment of attention deficit hyperactivity disorder. Intellipharmaceutics has a license and commercialization agreement with Par Pharmaceutical, Inc. for the development and commercialization of generic Focalin XR. The company also has five generic products filed with the FDA, including a gene ric of Effexor XR (venlafaxine hydrochloride), an extended-release capsule for depression; Protonix (pantoprazole sodium), a delayed-release tablet for conditions associated with gastroesophageal disease; Glucophage XR (metformin hydrochloride), an extended-release tablet for managing type 2 diabetes; Seroquel XR (quetiapine fumarate), an extended-release tablet for the treatment of schizophrenia, bipolar disorder, and major depressive disorder; and Lamictal XR (lamotrigine), an extended-release tablet for the treatment of anti-convulsant for epilepsy. Its lead non-generic product under development is Rexista (oxycodone), an abuse- and alcohol-deterrent controlled-release oral oxycodone hydrochloride formulation for the relief of pain. The company also has a under late stage development product, such as Coreg CR (carvedilol phosphate), an extended-release capsule for hypertension and heart conditions. IntelliPharmaCeutics International Inc. was founded in 1998 and is based i n Toronto, Canada.
Advisors' Opinion:- [By Roberto Pedone]
A pharmaceutical player that's starting to trend within range of triggering a big breakout trade is IntelliPharmaCeutics (IPCI), which specializing in the research, development and manufacture of generic controlled-release and targeted-release oral solid dosage drugs. This stock has been on fire over the last three months, with shares up a whopping 99%.
If you take a look at the chart for IntelliPharmaCeutics, you'll notice that this stock has been uptrending a bit over the last few weeks, with shares moving higher from its low f $3.12 to its recent high of $4.37 a share. During that uptrend, shares of IPCI have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of IPCI within range of triggering a big breakout trade above some key overhead resistance levels.
Traders should now look for long-biased trades in IPCI if it manages to break out some near-term overhead resistance levels at $4.37 to $4.62 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 1.31 million shares. If that breakout triggers soon, then IPCI will set up to re-test or possibly take out its 52-week high at $6.46 a share.
Traders can look to buy IPCI off any weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $3.36 or at its 50-day moving average of $3.13 a share. One could also buy IPCI off strength once it starts to take out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
5 Best Asian Stocks To Invest In Right Now: Carbo Ceramics Inc. (CRR)
CARBO Ceramics Inc. manufactures and supplies resin-coated ceramic and resin-coated sand proppants primarily used in the hydraulic fracturing of natural gas and oil wells in the United States and internationally. The company offers proppants, including CARBOHSP and CARBOPROP designed for use in deep gas wells; CARBOLITE used in medium depth oil and gas wells; CARBOECONOPROP; CARBOHYDROPROP used to enhance performance in slickwater fracture treatments; CARBOBOND LITE for oil and natural gas wells that are subject to the risk of proppant flow-back; and CARBOBOND RCS, a conductivity proppant. It also provides fracture simulation software, as well as offers fracture design, engineering, and consulting services to oil and natural gas companies. In addition, the company provides a range of technologies for spill prevention, containment, countermeasures, and geotechnical monitoring, as well as offers monitoring systems and services for bridges, buildings, tunnels, dams, slopes, e mbankments, volcanoes, landslides, mines, and construction projects primarily for customers in auto racing teams, surveyors, experimental physicists, radio astronomers, and naval architects markets. It principally sells its products and services to operators of oil and natural gas wells, and oilfield service companies. The company was founded in 1987 and is headquartered in Houston, Texas.
Advisors' Opinion:- [By Maxx Chatsko]
Over the last two weeks, we have looked at a number of catalysts and risks for the world's largest ceramic proppant manufacturer CARBO Ceramics (NYSE: CRR ) . The list includes:
- [By Aaron Levitt]
At its core, CARBO Ceramics (CRR) manufactures synthetic proppants used in oil and gas drilling. The takeaway for E&P firms willing to cough up the extra bucks for ��rtificial sand��is that they are able to squeeze out more natural gas and shale oil from wells using CRR�� products — about 20% more. That extra production, especially given the high price for oil, can mean the difference between whether a project is profitable or not.
- [By Maxx Chatsko]
Analysts and investors have penciled in CARBO Ceramics (NYSE: CRR ) , the world's leading ceramic proppant manufacturer, for some above-average growth in the coming years. Proppants are tiny beads that are pumped into an oil or gas well to keep fractures "propped open" and hydrocarbons flowing. It's easy to see how companies such as CARBO can succeed by enabling the American energy industry during one of the biggest energy booms in history. Management may be a little more difficult to pin down, so let's take a closer look.
5 Best Asian Stocks To Invest In Right Now: Templeton Russia Fund Inc.(TRF)
Templeton Russia and East European Fund Inc. is a closed-ended mutual fund launched by Franklin Templeton Investments. It is managed by Templeton Asset Management Ltd. The fund invests in public equity markets in Russia and Eastern Europe. It focuses on investments across diversified sectors. The fund employs a value-oriented approach to invest in companies. It focuses on market price of a company's securities relative to the evaluation of the company's long-term earnings, asset value, and cash flow potential for selecting individual securities. The fund also considers positioning of security in the sector, the economic framework, and political environment to create its portfolio. Templeton Russia and East European Fund Inc was formed in June 15, 1995 and is domiciled in the United States.
Advisors' Opinion:- [By STANSBERRYRESEARCH]
The Templeton Russia Fund (TRF) is about to get crushed again. Stuffed with Russian oil and bank stocks, this ETF is one of the few direct Russia plays in the market... This spring, the premium on TRF hit a whopping 35%. You had to pay $1.35 for every $1 of real value. This huge overvaluation was corrected when emerging markets got obliterated in May. The Russia Fund fared the worst, falling 47% from its peak.
5 Best Asian Stocks To Invest In Right Now: Air Methods Corporation(AIRM)
Air Methods Corporation, together with its subsidiaries, provides air medical emergency transport services and systems in the United States. It transports persons requiring intensive medical care from either the scene of accident or general care hospitals to highly skilled trauma centers or tertiary care centers. The company operates through three segments: Community-Based Services, Hospital-Based Services, and United Rotorcraft. The Community-Based Services segment provides air medical transportation services, including aircraft operation and maintenance, medical care, dispatch and communications, and medical billing and collection services. This segment operates 201 helicopters and 15 fixed wing aircraft in 29 states. The Hospital-Based Services segment offers air medical transportation services, and medically equipped helicopters and airplanes for hospitals. It operates 212 helicopters and 6 fixed wing aircraft in 34 states. The United Rotorcraft segment designs, manufa ctures, installs, and certifies modular medical interiors, multi-mission interiors, and other aerospace and medical transport products for domestic and international customers, as well as provides quality assurance and certification services. Air Methods Corporation was founded in 1982 and is headquartered in Englewood, Colorado.
Advisors' Opinion:- [By Chris Hill]
We closed today's show with two stocks to watch. Motley Fool analyst Jason Moser has Air Methods (NASDAQ: AIRM ) on his radar. And analyst Matt Argersinger is watching Universal Display (NASDAQ: OLED ) .
No comments:
Post a Comment